Madrigal Pharmaceuticals
MDGL51
$266.67arrow_drop_down2.08%-$5.69
High Growth
MDGL51
$266.67
arrow_drop_down2.08%Performance History
| Key Stats | |
|---|---|
| Open | $270.00 |
| Prev. Close | $273.35 |
| EPS | -21.90 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 266.37 | 275.88 |
| 52 Week Range | 119.76 | 376.70 |
| Ratios | |
|---|---|
| EPS | -21.90 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Madrigal Pharmaceuticals (MDGL)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Paul A. Friedman M.D.
- Headquarters
- West Conshohocken
- Employees
- 92
- Exchange
- NASDAQ
Keep an eye on Madrigal Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.